Strategic directions in the management of women with migraine attacks during pregnancy


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper analyzes the data available in the literature on the topic: migraine attacks during pregnancy and strategic approaches to managing women with migraine during this period. It shows the relevance of diagnosis and therapy in women with migraine attacks during pregnancy. The main management principles for this category of patients are non-drug interventions, behavioral recommendations, safe and effective headache attack relief, and, if necessary, preventive therapy. This can significantly reduce disadaptation and improve quality of life in women during this period. Further investigations are needed to determine effective and safe therapeutic approaches in the presence of headache attacks in women with migraine during pregnancy.

Full Text

Restricted Access

About the authors

Evgenia V. Ekusheva

Academy of Postgraduate Education under the Federal State Budgetary Institution Federal State Budgetary Unit «Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency»

Email: ekushevaev@mail.ru
MD, professor

References

  1. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053): 1545-602. doi: 10.1016/S0140-6736(16)31678-6
  2. Tietjen G.E., Collins S.A. Hypercoagulability and migraine. Headache. 2018; 58(1): 173-83. http://dx.doi.org/10.1111/head.13044
  3. Bakar N.A., Tanprawate S., Lambru G., Torkamani M., Jahanshahi M., Matharu M. Quality of life in primary headache disorders: a review. Cephalalgia. 2016; 36(1): 67-91. doi: 0.1177/0333102415580099
  4. Steiner T.J., Birbeck G.L., Jensen R.H., Zaza Katsarava Z., Stovner L.J., Martelletti P. Headache disorders are third cause of disability worldwide. J. Headache Pain. 2015; 16: 58. doi: 10.1186/s10194-015-0544-2
  5. Екушева Е.В., Дамулин И.В. Мигренозные приступы во время беременности: тактика ведения пациенток и приоритеты терапии. Российский медицинский журнал. 2014; 3: 41-8.
  6. MacGregor А. Menstrual migraine, migraine and contraceptions, migraine and pregnancy and migraine triggers. J. Headache Pain. 2013; 14(Suppl.1): O5. doi: 10.1186/1129-2377-1-S1-O5
  7. Contag S.A., Mertz H.L., Bushnell C.D. Migraine during pregnancy: is it more than a headache? Nat. Rev. Neurol. 2009; 5(8): 449-56. doi: 10.1038/ nrneurol.2009.100
  8. Elliott D., Li X., Zhu P., Gaitour E. Headache in pregnancy. In: Minagar A., ed. Neurological disorders and pregnancy. London: Elsevier; 2011: 19-37. doi: 10.1016/b978-0-12-384911-3.00002-6
  9. Goadsby P.J., Goldenberg J., Silberstein S.D. Migraine in pregnancy. BMJ. 2008; 336(7659): 1502-4. doi: 10.1136/bmj.39559.675891.ad
  10. Bigal M.E., Lipton R.B. The epidemiology, burden, and comorbidities of migraine. Neurol. Clin. 2009; 27(2): 321-34. doi: 10.1016/ j.ncl.2008.11.011
  11. Kvisvik E.V., Stovner L.J., Heide G., Bovim G., Linde M. Headache and migraine during pregnancy and puerperium: the MIGRA-study. J. Headache Pain. 2011; 12(4): 443-51. doi: 10.1007/s10194-011-0329-1
  12. Ertresvâg J.M., Stovner L.J., Kvavik L.E., Johnsen H.-J., Zwart J.-A., Heide G. et al. Migraine aura or transient ishemic attaks? A five-year follow-up case-control study of women with transient central nervous system disorders in pregnancy. BMJ Medicine. 2007; 5: 19-26. doi: 10.1186/1741-7015-5-19/
  13. Turner D.P., Smitherman T.A., Eisenach J.C., Penzien D.B., Houle T.T. Predictors of headache before, during, and after pregnancy: a cohort study. Headache. 2012; 52(3): 348-62. doi: 10.1111/j.1526-4610.2011.02066.x
  14. MacGregor E.A. Estrogen and migraine: correlations and prevention. Headache. 2008; 48(Suppl. 2): S99-107. doi: 10.1111/j.1526-4610.2008.01202.x
  15. Duong S., Bozzo P., Nordeng H., Einarson A. Safety of triptans for migraine headaches during pregnancy and breastfeeding. Can. Fam. Physician. 2010; 56(6): 537-9.
  16. Serva W.A., Serva V.M., Caminha M.F.C., Figueiroa J.N., Albuquerque E.C., Serva G.B.D. et al. Course of migraine during pregnancy among migraine sufferers before pregnancy. Arq. Neuropsiquiatr. 2011; 69(4): 613-9. doi: 10.1590/s0004-282x2011000500008
  17. Jalilian N., Fakheri T., Daeichin S., Vakilifar F. Migraine management in pregnancy. J. Inj. Violence Res. 2012; 4(3, Suppl.1): 78.
  18. Calhoun A.H. Migraine treatment in pregnancy and lactation. Curr. Pain Headache Rep. 2017; 21(11): 46. doi: 10.1007/s11916-017-0646-4.
  19. Soldin O.P., Dahlin J., O'Mara D.M. Triptans in pregnancy. Ther. Drug Monit. 2008; 30(1): 5-9. doi: 10.1097/ftd.0b013e318162c89b.
  20. Marcus D.A. Managing headache during pregnancy and lactation. Expert Rev. Neurother. 2008; 8(3): 385-95. doi: 10.1586/14737175.8.3.385
  21. Nappi R.E., Albani F., Sances G., Terreno E., Brambilla E., Polatti F. Headaches during pregnancy. Curr. Pain Headache Rep. 2011; 15(4): 289-94. doi: 10.1007/ s11916-011-0200-8
  22. Amundsen S., Nordeng H., Nezvalova-Henriksen K., Stovner L.J., Spigset O. Pharmacological treatment of migraine during pregnancy and breastfeeding. Nat. Rev. Neurol. 2015; 11: 209-19. doi: 10.1038/nrneurol.2015.29
  23. Liberman A., Karussis D., Ben-Hur T., Abramsky O., Leker R.R. Natural course and pathogenesis of transient focal neurologic symptoms during pregnancy. Arch. Neurol. 2008; 65(2): 218-20. doi: 10.1001/archneurol.2007.50
  24. Chen S.P., Fuh J.L., Wang S.J. Reversible cerebral vasoconstriction syndrome: current and future perspectives. Expert Rev. Neurother. 2011; 11(9): 1265-76. doi: 10.1586/ern.11.112
  25. Allais G., Gabellar I.C., Borgogno P., Lorenzo C.D., Benedetto C. The risks of women with migraine during pregnancy. Neurol. Sci. 2010; 31(Suppl. 1): S59-61. doi: 10.1007/s10072-010-0274-9
  26. Hosley C.M., McCullough L.D. Acute neurological issues in pregnancy and the peripartum. The Neurohospitalist. 2011; 1(2): 104-16. doi: 10.1177/1941875211399126
  27. Kanal E., Barkovich A.J., Bell C., Borgstede J.P., Bradley W.G., Froelich J.W. et al.; Expert panel on MR safety. ACR guidance document on MR safe practices: 2013. J. Magn. Reson. Imaging. 2013; 37(3): 501-30. doi: 10.1002/jmri.24011
  28. Damak M., Crassard I., Wolf V., Bousser M.-G. Isolated lateral sinus thrombosis. A series of 62 patients. Stroke. 2009; 40(2): 476-81. doi: 10.1161/ strokeaha.107.509711
  29. Екушева Е.В., Дамулин И.В. Современные подходы к терапии мигрени во время беременности. Журнал неврологии и психиатрии имени С.С. Корсакова. 2015; 115(11): 124-32.
  30. Wabnitz A., Bushnell C. Migraine, cardiovascular disease, and stroke during pregnancy: systematic review of the literature. Cephalalgia. 2015; 35(2): 132-9. https://doi.org/10.1177/0333102414554113
  31. MacGregor A. Management of migraine during pregnancy. Progr. Neurol. Psychiatr. 2009; 13(5): 21-4. https://doi.org/10.1002/pnp.137
  32. Evans E.W., Lorber K.C. Use of 5-HT1 agonists in pregnancy. Ann. Pharmacother. 2008; 42(4): 543-9. doi: 10.1345/aph.1k176
  33. Bobker S., Klebanoff L., Broner S. Migraine in women. Neurology. 2017; 37(6): 601-10. https://doi.org/10.1055/s-0037-1607393
  34. Nezyalovä-Henriksen K., Spigset O., Nordeng H. Triptan safety during pregnancy: a Norwegian population registry study. Eur. J. Epidemiol. 2013; 28(9): 759-69. doi: 10.1007/s10654-013-9831-x
  35. Negro A., Delaruelle Z., Ivanova T.A., Khan S., Ornello R., Raffaelli B. et al. Headache and pregnancy: a systematic review. J. Headache Pain. 2017; 18(1):106. https://doi.org/10.1186/s10194-017-0816-0
  36. Chen H.M., Chen S.F., Chen Y.H., Lin H.C. Increased risk of adverse pregnancy outcomes for women with migraines: a nationwide population-based study. Cephalalgia. 2009; 30(4): 433-8. https://doi.org/10.1111/ j.1468-2982.2009.01935.x
  37. Menon R., Bushnell C.D. Headache and pregnancy. Neurologist. 2008; 14(2): 108-19. doi: 10.1097/nrl.0b013e3181663555
  38. Amundsen S., 0vreb0 T.G., Amble N.M.S., Poole A.C., Nordeng H. Use of antimigraine medications and information needs during pregnan cy and breastfeeding: a cross-sectional study among 401 Norwegian women. Eur. J. Clin. Pharmacol. 2016; 72(12): 1525-35. doi: 10.1007/ s00228-016-2127-9
  39. Екушева Е.В. Оптимальные подходы к купированию приступа мигрени: прошлое, настоящее и будущее. Русский медицинский журнал. 2012; 20(10): 522-8.
  40. Nijjar S.S., Rosenberg J., Peterlin B.L. Migraine in women. In: Chin M.L., Fillingim R.B., Ness T.J., eds. Pain in women. New York: Oxford University Press; 2010: 297-309. doi: 10.1093/med/9780199796410.003.0021

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2019 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies